L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition

Detalhes bibliográficos
Autor(a) principal: La Fuente, J
Data de Publicação: 2019
Outros Autores: Fernández, A, Pepe-Cardoso, A, Martínez-Salamanca 4, J Nuno Louro 1, Javier Angulo 5, Louro, N, Angulo, J
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/2343
Resumo: The aim was to evaluate and characterize H2S-induced relaxation of human corpus cavernosum (HCC) and penile resistance arteries (HPRA) from patients with erectile dysfunction (ED). HCC and HPRA were obtained from men with ED at the time of penile prosthesis insertion. H2S-mediated relaxations were evaluated by exposing these tissues to the stable analogue, NaHS, and to the precursor of H2S, L-cysteine (CYS). The effects of NaHS and CYS were also evaluated on cGMP accumulation in HCC and on acetylcholine- and sildenafil-mediated relaxations in HCC and HPRA. NaHS consistently relaxed HPRA and HCC and more potently than human prostate and bladder. NaHS-induced relaxations in HCC and HPRA were unaffected by the ATP-sensitive K+-channel blocker, glibenclamide or the NO synthase inhibitor, L-NAME, slightly reduced by the Ca2+-activated K+-channel blocker, tetraethylammonium, and markedly inhibited by the soluble guanylyl cyclase inhibitor, ODQ. NaHS caused a cGMP increase in HCC that was inhibited by ODQ. CYS produced relaxations of HCC and HPRA that were sensitive to ODQ and to inhibition of the H2S synthesizing enzymes, cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS). CYS also increased cGMP in HCC. In contrast to NaHS, CYS-induced relaxations were prevented by endothelium removal in HPRA. Only in HPRA, treatment with CYS (30 μM) potentiated acetylcholine- and sildenafil-induced relaxations. This effect was prevented by CSE/CBS inhibition and by removing the endothelium. Exogenous and endogenous H2S relaxes HCC and HPRA from ED patients through cGMP accumulation and potentiates vasodilatory capacity of PDE5 inhibition, supporting the therapeutic potential of modulating H2S pathway.
id RCAP_70d49f17cba38b3a1301868c14a1bc4f
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/2343
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 InhibitionErectile dysfunctionL-cysteineThe aim was to evaluate and characterize H2S-induced relaxation of human corpus cavernosum (HCC) and penile resistance arteries (HPRA) from patients with erectile dysfunction (ED). HCC and HPRA were obtained from men with ED at the time of penile prosthesis insertion. H2S-mediated relaxations were evaluated by exposing these tissues to the stable analogue, NaHS, and to the precursor of H2S, L-cysteine (CYS). The effects of NaHS and CYS were also evaluated on cGMP accumulation in HCC and on acetylcholine- and sildenafil-mediated relaxations in HCC and HPRA. NaHS consistently relaxed HPRA and HCC and more potently than human prostate and bladder. NaHS-induced relaxations in HCC and HPRA were unaffected by the ATP-sensitive K+-channel blocker, glibenclamide or the NO synthase inhibitor, L-NAME, slightly reduced by the Ca2+-activated K+-channel blocker, tetraethylammonium, and markedly inhibited by the soluble guanylyl cyclase inhibitor, ODQ. NaHS caused a cGMP increase in HCC that was inhibited by ODQ. CYS produced relaxations of HCC and HPRA that were sensitive to ODQ and to inhibition of the H2S synthesizing enzymes, cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS). CYS also increased cGMP in HCC. In contrast to NaHS, CYS-induced relaxations were prevented by endothelium removal in HPRA. Only in HPRA, treatment with CYS (30 μM) potentiated acetylcholine- and sildenafil-induced relaxations. This effect was prevented by CSE/CBS inhibition and by removing the endothelium. Exogenous and endogenous H2S relaxes HCC and HPRA from ED patients through cGMP accumulation and potentiates vasodilatory capacity of PDE5 inhibition, supporting the therapeutic potential of modulating H2S pathway.ElsevierRepositório do Hospital Prof. Doutor Fernando FonsecaLa Fuente, JFernández, APepe-Cardoso, AMartínez-Salamanca 4, J Nuno Louro 1, Javier Angulo 5Louro, NAngulo, J2019-12-11T12:06:17Z2019-01-01T00:00:00Z2019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/2343engEur J Pharmacol, 863,172675 2019 Nov 151879-071210.1016/j.ejphar.2019.172675metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:53:02Zoai:repositorio.hff.min-saude.pt:10400.10/2343Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:53:17.332358Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
title L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
spellingShingle L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
La Fuente, J
Erectile dysfunction
L-cysteine
title_short L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
title_full L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
title_fullStr L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
title_full_unstemmed L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
title_sort L-cysteine/hydrogen Sulfide Pathway Induces cGMP-dependent Relaxation of Corpus Cavernosum and Penile Arteries From Patients With Erectile Dysfunction and Improves Arterial Vasodilation Induced by PDE5 Inhibition
author La Fuente, J
author_facet La Fuente, J
Fernández, A
Pepe-Cardoso, A
Martínez-Salamanca 4, J Nuno Louro 1, Javier Angulo 5
Louro, N
Angulo, J
author_role author
author2 Fernández, A
Pepe-Cardoso, A
Martínez-Salamanca 4, J Nuno Louro 1, Javier Angulo 5
Louro, N
Angulo, J
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv La Fuente, J
Fernández, A
Pepe-Cardoso, A
Martínez-Salamanca 4, J Nuno Louro 1, Javier Angulo 5
Louro, N
Angulo, J
dc.subject.por.fl_str_mv Erectile dysfunction
L-cysteine
topic Erectile dysfunction
L-cysteine
description The aim was to evaluate and characterize H2S-induced relaxation of human corpus cavernosum (HCC) and penile resistance arteries (HPRA) from patients with erectile dysfunction (ED). HCC and HPRA were obtained from men with ED at the time of penile prosthesis insertion. H2S-mediated relaxations were evaluated by exposing these tissues to the stable analogue, NaHS, and to the precursor of H2S, L-cysteine (CYS). The effects of NaHS and CYS were also evaluated on cGMP accumulation in HCC and on acetylcholine- and sildenafil-mediated relaxations in HCC and HPRA. NaHS consistently relaxed HPRA and HCC and more potently than human prostate and bladder. NaHS-induced relaxations in HCC and HPRA were unaffected by the ATP-sensitive K+-channel blocker, glibenclamide or the NO synthase inhibitor, L-NAME, slightly reduced by the Ca2+-activated K+-channel blocker, tetraethylammonium, and markedly inhibited by the soluble guanylyl cyclase inhibitor, ODQ. NaHS caused a cGMP increase in HCC that was inhibited by ODQ. CYS produced relaxations of HCC and HPRA that were sensitive to ODQ and to inhibition of the H2S synthesizing enzymes, cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS). CYS also increased cGMP in HCC. In contrast to NaHS, CYS-induced relaxations were prevented by endothelium removal in HPRA. Only in HPRA, treatment with CYS (30 μM) potentiated acetylcholine- and sildenafil-induced relaxations. This effect was prevented by CSE/CBS inhibition and by removing the endothelium. Exogenous and endogenous H2S relaxes HCC and HPRA from ED patients through cGMP accumulation and potentiates vasodilatory capacity of PDE5 inhibition, supporting the therapeutic potential of modulating H2S pathway.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-11T12:06:17Z
2019-01-01T00:00:00Z
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/2343
url http://hdl.handle.net/10400.10/2343
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur J Pharmacol, 863,172675 2019 Nov 15
1879-0712
10.1016/j.ejphar.2019.172675
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130399716147200